BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4214480)

  • 1. Influence of glyburide on the antidiuretic response induced by 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JR; Szende L; Marosi J
    Metabolism; 1974 Nov; 23(11):1057-63. PubMed ID: 4214480
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study of the antidiuretic effects of Adiuretin-SD (DDAVP) and Pitressin Tannate in diabetes insipidus.
    Czakó L; Julesz J; László FA
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):10-3. PubMed ID: 631964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual differences in the antidiuretic response induced by single doses of 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Marosi J; Borbély L; Takó J
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):259-65. PubMed ID: 1002361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the diuretic effect of glibenclamide in healthy subjects and in patients with pituitary and nephrogenic diabetes insipidus.
    Radó JP; Borbély L; Szende L; Fischer J; Takó J
    Horm Metab Res; 1974 Jul; 6(4):289-92. PubMed ID: 4213198
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
    Radó JP; Marosi J; Fischer J; Takó J; Kiss N
    Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of clofibrate-induced antidiuresis by glybenclamide in patients with pituitary diabetes insipidus.
    Radó JP; Szende L
    J Clin Pharmacol; 1974; 14(5-6):290-5. PubMed ID: 4208361
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of the diuretic action of glibenclamide by clofibrate, carbamazepine and 1-deamino-8-d-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Szende L; Marosi J; Juhos E; Sawinsky I; Takó J
    Acta Diabetol Lat; 1974; 11(3):179-97. PubMed ID: 4218049
    [No Abstract]   [Full Text] [Related]  

  • 8. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
    Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A vasopressin analogue in treatment of diabetes insipidus.
    Kauli R; Laron Z
    Arch Dis Child; 1974 Jun; 49(6):482-5. PubMed ID: 4850356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased antidiuretic response to lysine-vasopressin after acute administration of glibenclamide in healthy subjects.
    Radó JP; Borbély L; Szende L; Takó J
    Acta Diabetol Lat; 1974; 11(1):18-21. PubMed ID: 4216226
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of the antidiuretic effect of 1-deamino-8d-arginine vasopressin (DDAVP) by glibenclamide in water-loaded healthy subjects.
    Radó JP; Borbély L
    Endokrinologie; 1975 Sep; 66(1):88-93. PubMed ID: 817889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiuretic antagonism and agonism of 1-deamino-pentamethylene-2-D-phenylalanine-4-isoleucine-arginine vasopressin in rats with diabetes insipidus.
    Vilhardt H; Lundin S
    J Endocrinol; 1987 Mar; 112(3):439-42. PubMed ID: 3559452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lengthening of the duration of action of DDAVP by "ineffective" doses of clofibrate in patients with pituitary diabetes insipidus.
    Radó JP; Marosi J
    Endokrinologie; 1976 Jun; 67(2):220-9. PubMed ID: 954691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of diabetes insipidus in children with DDAVP, a synthetic analogue of vasopressin.
    Aronson AS; Andersson KE; Bergstrand CG; Mulder JL
    Acta Paediatr Scand; 1973 Mar; 62(2):133-40. PubMed ID: 4691456
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence that glyburide-induced diuresis is not mediated by inhibition of ADH.
    Moses AM; van Gemert M; Miller M
    Horm Res; 1974; 5(6):359-66. PubMed ID: 4214743
    [No Abstract]   [Full Text] [Related]  

  • 16. DDAVP in the treatment of diabetes insipidus: a clinical study.
    Graham JJ; Wise PH; Harding PE
    Med J Aust; 1977 Jul; 2(4):113-6. PubMed ID: 895639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shortened duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with diabetes insipidus requiring high doses of peroral antidiuretic drugs.
    Radó JP; Marosi J; Fischer J
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):518-24. PubMed ID: 789414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of diabetes insipidus with 1-desamino-8-D-arginine-vasopressin (author's transl)].
    Irmscher K; Sennejunker K; Wiegelmann W; Solbach HG
    Dtsch Med Wochenschr; 1974 Nov; 99(48):2431-7. PubMed ID: 4614967
    [No Abstract]   [Full Text] [Related]  

  • 20. Antidiuretic responses to injected desmopressin, alone and with indomethacin.
    Moses AM; Moses LK; Notman DD; Springer J
    J Clin Endocrinol Metab; 1981 May; 52(5):910-3. PubMed ID: 7228994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.